Empagliflozin and linagliptin and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Empagliflozin and linagliptin and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Kitabis Pak
- Empagliflozin and linagliptin-Kitabis Pak inhalation
- Empagliflozin and linagliptin-Klofensaid II
- Empagliflozin and linagliptin-Klonopin
- Empagliflozin and linagliptin-Klonopin Wafer
- Empagliflozin and linagliptin-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Empagliflozin and metformin
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Empagliflozin and Metformin Extended-Release Tablets
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Empagliflozin and Metformin Tablets
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Empliciti
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Emsam
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Emsam Transdermal